"Paving the Way for a Safer World Through Advanced Emergency Communications"

TORONTO, ON / ACCESSWIRE / August 24, 2023 / Bionoid Pharma, Inc. ("BINP" or the "Company") (OTC PINK:BINP) is pleased to announce the extension of the effective period of a Letter of Intent (LOI), along with its exclusivity provisions, with Global Alerts Corp., as initially disclosed on March 22, 2023. The Company confirmed that the LOI, originally set to expire on August 16, 2023, has been extended to the earlier of: (i) the date of execution of a definitive agreement, or (ii) November 14, 2023. This extension facilitates the comprehensive due diligence process between Global Alerts Corp. and Bionoid Pharma.

Wayne Cockburn, CEO of Bionoid Pharma, expressed the significance of this extension, stating, "This marks a crucial stride toward finalizing a definitive and legally binding agreement that embodies the shared vision of both organizations. It is important to note that no other amendments to the Letter of Intent have been made."

Dan Pacholik, CEO of Global Alerts, underscored the significance of the extension, emphasizing, "This extension, particularly with its exclusivity provisions, underscores our unwavering commitment to transforming global emergency communication systems."

For additional details regarding the proposed transaction, please refer to BINP's news release dated March 22, 2023.

About Global Alerts Corp's Visionary Mission

Global Alerts Corp., a distinguished Canadian-controlled company, remains steadfast in its mission to provide a unified mass notification platform to the 6 billion individuals worldwide lacking access to critical mass emergency alert and notification capabilities. Through its exclusive affiliations with CEASA Group and One World UPSEN Alliance Inc., a non-profit organization, Global Alerts Corp. assumes the responsibility of delivering a fully automated regional, national, and global emergency mass messaging platform known as UPSEN.

The UPSEN platform empowers nations with an "authoritative alert capability" via licensed commercial wireless carriers, revolutionizing the dissemination of critical information. This visionary approach guarantees that all active mobile devices within a nation connected to UPSEN receive pre- and post-emergency event information from a UN-recognized agency affiliated with the Alliance.

For a comprehensive exploration of Global Alerts Corp.'s transformative initiatives, please visit the company's official website: www.globalalertscorp.com .

About Bionoid Pharma (OTC: BINP)

Bionoid Pharma is a healthcare company dedicated to the development of products and technologies in the expanding health and wellness sector. The company presently offers a range of products designed to alleviate pain, enhance recovery time, and improve overall physical well-being.

For media inquiries, please contact:

Wayne Cockburn, CEO
Phone: (905) 505-0770

Note: This press release is a forward-looking statement and contains certain forward-looking information. The forward-looking information is based on certain key expectations and assumptions made by the management of Bionoid Pharma. The forward-looking information is subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Readers are cautioned not to place undue reliance on forward-looking information.

SOURCE: Bionoid Pharma, Inc.